Statistics
Te Tari Pāngarau me te Tatauranga
Department of Mathematics & Statistics
Back to Our people

Assoc Prof Katrina Sharples

Office: Science III, room 233
Phone: 479-7605
Email: katrina.sharples@otago.ac.nz

** Head of Statistics **

Research Interests

I am a biostatistician, with a PhD in Biostatistics from the University of Washington, Seattle. I have fairly broad interests in statistical methods for clinical and epidemiological research, with particular expertise in clinical trials. I am the lead statistician for Cancer Trials New Zealand, the Pharmacoepidemiology Research Network and the Centre for International Health and am a member of the Otago Global Health Institute and the Centre for Translational Research in Cancer. My main areas of application are cancer, infectious disease and respiratory disease. I chair the Health Research Council Data Monitoring Committee. My time is divided between the Department of Mathematics and Statistics and the Department of Medicine.

Recent publications

Paul, C., Sharples, K. J., Baranyai, J., Jones, R. W., & Skegg, D. C. G. Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix. Australian & New Zealand Journal of Obstetrics & Gynaecology. 2018; 58: 321–329. doi: 10.1111/ajo.12753

Sharples, K, Firth M, Hinder V, Hill A, Jeffery M, Sarfati D, Brown C, Atmore C, Lawrenson R, Reid P, Derrett S, Macapagal J, Keating J, Secker A, De Groot C, Jackson C, Findlay M. The New Zealand PIPER Project: colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation—results from a retrospective cohort study. New Zealand Medical Journal 2018; 131 (No 1476):24-39 7852

Gasser O, Sharples KJ, Barrow C, Williams GM, Bauer E, Wood CE, Mester B, Dzhelali M, Caygill G, Jones J, Hayman CM, Hinder VA, Macapagal J, McCusker M, Weinkove R, Painter GF, Brimble MA, Findlay MP, Dunbar PR, Hermans IF. A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. Cancer Immunology Immunotherapy 2018; 67(2):285-98. DOI: 10.1007/s00262-017-2085-9

Parkin L, Barson D, Zeng J, Horsburgh S, Sharples K, Dummer J. Patterns of use of long‐acting bronchodilators in patients with COPD: A nationwide follow‐up study of new users in New Zealand. Respirology 2018; 23 (6), 583-592 DOI: 10.1111/resp.13235

Maze MJ, Cash-Goldwasser, S, Rubach, MP, Biggs, HM, Galloway RL, Sharples, KJ, Allan KJ, Halliday JEB, Cleaveland S, Shand MC, Muiruri C, Kazwala RR, Saganda, W, Lwezaula BF, Mmbaga BT, Maro VP, .Crump, JA. Risk factors for human acute leptospirosis in northern Tanzania. PLOS Neglected Tropical Diseases 2018; 12(6). doi: 10.1371/journal.pntd.0006372

Quon J, Parkin L, Sharples K, Barson D. Co-prescribing of contraindicated and use-with-caution drugs in a national cohort of new users of simvastatin: how well are prescribing guidelines followed? The New Zealand Medical Journal (Online) 2018; 131 (1474), 35-44

Cash-Goldwasser S, Maze MJ, Rubach MP, Biggs HM, Stoddard RA, Sharples KJ, Halliday JEB, Cleaveland S, Shand MC, Mmbaga BT, Muiruri C, Saganda W, Lwezaula BF, Kazwala RR, Maro VP, Crump JA. Risk factors for human brucellosis in northern Tanzania. The American journal of tropical medicine and hygiene 2018; 98 (2): 598-606 doi: 10.4269/ajtmh.17-0125

Parkin L, Sharples KJ, Barson DJ, Blank M-L. Simvastatin dose and acute kidney injury without concurrent serious muscle injury: A nationwide nested case-control study. PLoS ONE 2018; 12(7): e0182066. doi: 10.1371/journal.pone.0182066